Meeder Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,032
| Closed | -$20K | – | 865 |
|
|
2022
Q3 | $20K | Buy |
+1,032
| New | +$20K | ﹤0.01% | 1100 |
|
|
2021
Q4 | – | Sell |
-2,683
| Closed | -$64K | – | 1215 |
|
|
2021
Q3 | $64K | Buy |
2,683
+406
| +18% | +$9.69K | ﹤0.01% | 1021 |
|
|
2021
Q2 | $62K | Buy |
2,277
+904
| +66% | +$24.6K | ﹤0.01% | 1052 |
|
|
2021
Q1 | $40K | Buy |
+1,373
| New | +$40K | ﹤0.01% | 1175 |
|
|
2020
Q4 | – | Sell |
-403
| Closed | -$11K | – | 1869 |
|
|
2020
Q3 | $11K | Buy |
+403
| New | +$11K | ﹤0.01% | 1332 |
|
|
2020
Q2 | – | Sell |
-14
| Closed | – | – | 2046 |
|
|
2020
Q1 | $0 | Buy |
+14
| New | – | ﹤0.01% | 2321 |
|